spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  bioresorbable 

 HSMN NewsFeed - 9 Jun 2025
TYBR Health Announces FDA 510(k) Clearance for B3 GEL(TM) System, a Flowable Bio-Gel to Protect Healing Tissue and Preserve Function
Devices Regenerative Medicine Surgery FDA
 HSMN NewsFeed - 8 Oct 2024
Regenity Biosciences Receives 510(k) Clearance for RejuvaKnee(TM), a Groundbreaking Regenerative Meniscus Implant Device to Redefine the Standard of Care
Devices Orthopaedic FDA
 HSMN NewsFeed - 7 Oct 2024
Medinol Announces Successful First-in-Human Implantation of ChampioNIR Drug-Eluting Peripheral Stent System in Australia
Devices Interventional
 HSMN NewsFeed - 13 Mar 2024
Ventris Medical Receives 510(k) Additional Clearance for Amplify(R) Standalone Bone Graft Putty
Devices FDA
 HSMN NewsFeed - 14 Feb 2024
Efemoral Medical Granted Breakthrough Device Designation
Devices Interventional FDA
 HSMN NewsFeed - 30 May 2023
GT Medical Technologies Marks a Clinical Milestone: 200th Patient Enrolled in the Multicenter Observational Registry of GammaTile(R) Therapy
Devices Neurosurgery Oncology
 HSMN NewsFeed - 30 Mar 2023
FDA approves Bioretec's RemeOs(TM) trauma screw as the first bioresorbable metal implant in the U.S. market
Devices Orthopaedic FDA
 HSMN NewsFeed - 13 Sep 2022
Ventris Medical Receives 510(k) Clearance for Amplify(R) Standalone Bone Graft Putty and Bone Graft Extender
Devices Regenerative Medicine FDA
 HSMN NewsFeed - 11 May 2022
Acera Surgical Announces Michael Finegan as New CEO
Devices Surgery Wound Care Personnel
 HSMN NewsFeed - 25 Apr 2022
MedTech Company STENTiT Raises €1.8 million in Seed Round
Devices Interventional Venture Capital
 HSMN NewsFeed - 8 Feb 2022
atHeart Medical Receives FDA Approval for the Second Phase of the ASCENT ASD U.S. IDE Trial
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 24 Jan 2022
Lyra Therapeutics Announces Initiation of LYR-210 Pivotal Phase 3 ENLIGHTEN Program in Surgically Naïve Chronic Rhinosinusitis Patients
Devices Drug Delivery
 HSMN NewsFeed - 31 Dec 2021
Bioretec Files for CE Mark for its Bioresorbable RemeOs Magnesium Screw in the EU
Devices Orthopaedic Regulatory
 HSMN NewsFeed - 8 Sep 2021
atHeart Medical Appoints Seasoned Medtech Executive Andrew Cleeland to Board of Directors
Devices Cardiology Personnel
 HSMN NewsFeed - 27 Jul 2021
BD Acquires Tepha, Inc., to Drive New Innovations in Soft Tissue Repair and Regeneration
Devices Regenerative Medicine Mergers & Acquisitions
 HSMN NewsFeed - 14 Jul 2021
First Five Patients Successfully Treated with atHeart Medical's Novel reSept(TM) Atrial Septal Defect Occluder in U.S. IDE Pivotal Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 15 Jun 2021
Dutch MedTech STENTiT appoints Golo von Basum as Chief Operating Officer
Devices Regenerative Medicine Personnel
 HSMN NewsFeed - 20 Apr 2021
Newly Formed Company, atHeart Medical, Aims to Evolve Septal Closure with the reSept(TM) ASD Occluder
Devices Interventional Cardiology
 HSMN NewsFeed - 29 Dec 2020
Collagen Matrix Acquires the GUIDOR(R) Synthetic Bone Graft & Membrane Business from Sunstar
Devices Acquisitions
 HSMN NewsFeed - 14 Dec 2020
Efemoral Medical Announces Successful First-In-Human Use of the Efemoral(TM) Vascular Scaffold System
Devices Interventional
 HSMN NewsFeed - 21 Oct 2020
Acuitive Technologies Granted FDA 510(k) Clearance for CITREGEN(TM) CITRELOCK(TM) Tendon Interference Screw System
Devices Orthopaedic FDA
 HSMN NewsFeed - 20 Jul 2020
New Medical Findings From 10-year Study of 3D Printed Regenerative Implant Osteoplug
Devices Regenerative Medicine
 HSMN NewsFeed - 1 Jul 2020
Carag Receives U.S. FDA IDE Approval to Conduct Clinical Study of First Transcatheter Septal Occluder With Bioresorbable, Metal-free Framework
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 25 Sep 2019
OrbusNeich(R) Announces Japan Approval for COMBO(R) Plus Coronary Stent
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 18 Jun 2019
Breakthrough Device Designation received from the FDA
Devices FDA
 HSMN NewsFeed - 19 Mar 2019
Atreon Orthopedics Received FDA Clearance for Rotator Cuff Regeneration Product
Devices Regenerative Medicine Orthopaedic FDA
 HSMN NewsFeed - 28 Aug 2017
ESC Congress 2017: BIOTRONIK's Orsiro Drug-Eluting Stent Outperforms Xience in BIOFLOW-V Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 17 May 2017
Xeltis' Technology for Natural Heart Valve Restoration Featured as the Future of Valve Therapy at EuroPCR
Devices Interventional Cardiology
 HSMN NewsFeed - 16 May 2017
Philips showcases new integrated image-guided therapy solutions at 2017 EuroPCR to transform cardiac care and help improve patient care
Devices Interventional Cardiology Radiology
 HSMN NewsFeed - 27 Apr 2017
Tepha Inc. Subsidiary, Galatea Surgical, Announces the Launch of GalaFORM(TM) 3D Surgical Scaffold
Devices Surgery FDA Product Launch
 HSMN NewsFeed - 20 Apr 2017
DePuy Synthes Acquires Tissue Regeneration System's 3D Printing Technologies to Treat Bone Defects
Devices Orthopaedic Acquisitions
 HSMN NewsFeed - 29 Mar 2017
Tepha Inc. Subsidiary, Galatea Surgical, Announces Launch of GalaSHAPE(TM) 3D Surgical Scaffold
Devices Surgery Product Launch
 HSMN NewsFeed - 5 Jan 2017
Abbott Completes the Acquisition of St. Jude Medical
Devices Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 30 Dec 2016
Innocoll Receives Refusal to File Letter from U.S. FDA for XARACOLL(R) (bupivacaine HCl collagen-matrix implants) New Drug Application
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 21 Nov 2016
OrbusNeich Introduces a New Generation COMBO Plus Dual Therapy Stent for Active Healing
Devices Interventional Cardiology Product Launch
 HSMN NewsFeed - 7 Nov 2016
Abbott's Absorb(TM) Bioresorbable Stent Approved as the First Fully Dissolving Heart Stent in Japan
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 20 Oct 2016
Akesys Medical and Elixir Medical Announce First Human Implant of the PRAVA(TM) Bioresorbable Scaffold for Peripheral Vascular Disease
Devices Interventional
 HSMN NewsFeed - 23 May 2016
NuVasive Launches Next Generation Biologics Technology
Devices Orthopaedic Neurosurgery Product Launch
 HSMN NewsFeed - 28 Apr 2016
Abbott to Acquire St. Jude Medical
Devices Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 16 Mar 2016
Abbott's Absorb(TM), the First Fully Dissolving Heart Stent, Earns Positive Review by FDA Advisory Committee
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 7 Jan 2016
QT Vascular Announces Clinical Outcomes of Its Chocolate Heart Drug Coated Coronary Balloon
Devices Interventional Cardiology
 HSMN NewsFeed - 15 Dec 2015
Svelte Medical Systems Announces CE Mark Certification of SLENDER IDS(TM)
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 12 Oct 2015
Abbott Announces Positive Clinical Results of Absorb(TM), the Naturally Dissolving Heart Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 18 Sep 2015
Elixir Medical Corporation Expands Commercial Operations with Addition of Michele Perrino as President, Commercial and Manufacturing Operations
Devices Interventional Personnel
 HSMN NewsFeed - 15 Jun 2015
Innocoll AG Announces First Patient Dosed in the Cogenzia COACT-2 Phase 3 Study for the Treatment of Diabetic Foot Infection
Devices Wound Care
 HSMN NewsFeed - 19 May 2015
Abbott Announces CE Mark for New Advancement of Absorb Stent System for People with Heart Disease
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 14 Jan 2015
Tissue Regeneration Systems Adds Business Development Executive
Devices Personnel
 HSMN NewsFeed - 18 Sep 2014
Latest Data Shows OrbusNeich's COMBO(TM) Dual Therapy Stent has Excellent Healing Benefits
Devices Interventional Cardiology
 HSMN NewsFeed - 13 May 2014
Elixir Medical Receives CE Mark Approval for the Breakthrough Fully Bioresorbable DESolve(R) 100 Novolimus Eluting Coronary Scaffold System
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 31 Oct 2013
Elixir Medical Announces Excellent 1-Year Safety and Efficacy Results for the CE-Marked Fully Bioresorbable DESolve(R) Novolimus Eluting Coronary Scaffold System
Devices Interventional Cardiology
 HSMN NewsFeed - 30 Oct 2013
REVA Announces Transmission of ReZolve2 Implant and Pilot Trial Update at TCT 2013
Devices Interventional Cardiology
 HSMN NewsFeed - 26 Aug 2013
Tissue Regeneration Systems Receives 510(k) Approval
Devices Neurosurgery FDA
 HSMN NewsFeed - 7 Aug 2013
TYRX Announces First U.S. Implantation of AIGISRx(R) R Fully Bioresorbable Antibacterial Envelope
Devices Cardiology Surgery
 HSMN NewsFeed - 9 Jul 2013
TYRX Receives FDA Clearance for Fully Resorbable AIGISRx(R) R Antibacterial Envelope
Devices Surgery Cardiology FDA
 HSMN NewsFeed - 24 May 2013
Elixir Medical Corporation Announces Outstanding Two-Year Results from the EXCELLA BD Randomized Clinical Trial for the CE Mark-Approved DESyne(R) BD System with Biodegradable Polymer Coating
Devices Interventional Cardiology
 HSMN NewsFeed - 8 May 2013
Elixir Medical Announces FDA Approval to Commence EXCELLA III Clinical Trial with DESyne(R) Nx Novolimus Eluting Coronary Stent System in the United States
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 8 Jan 2013
Abbott Initiates Clinical Trial of Absorb(TM) in the United States
Devices Interventional Cardiology
 HSMN NewsFeed - 24 Oct 2012
Elixir Medical Corporation Announces Outstanding Three-Year Data from the EXCELLA II Randomized Clinical Trial for the CE Mark-Approved DESyne(R) System
Devices Interventional Cardiology
 HSMN NewsFeed - 16 Oct 2012
OrbusNeich's COMBO Dual Therapy Stent(TM) to be Featured in Multiple Clinical Data Presentations Next Week at TCT 2012
Devices Interventional Cardiology
 HSMN NewsFeed - 25 Sep 2012
Abbott Announces International Launch of the Absorb(TM) Bioresorbable Vascular Scaffold
Devices Interventional Cardiology
 HSMN NewsFeed - 5 Sep 2012
DERMAGRAFT(R) Approved in Canada for Treatment of Diabetic Foot Ulcers
Devices Wound Care Regulatory
 HSMN NewsFeed - 28 Aug 2012
Elixir Medical Receives CE Mark Approval for the DESyne(R) BD Novolimus Eluting Coronary Stent System With Biodegradable Polymer Coating
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 16 May 2012
Elixir Medical Announces Excellent Results from DESolve I First-In-Man Study for the Fully Bioresorbable Drug Eluting Coronary Scaffold System
Devices Interventional Cardiology
 HSMN NewsFeed - 15 May 2012
Elixir Medical Announces Continued Excellent One Year Safety and Efficacy Data from the EXCELLA BD Randomized Clinical Trial for DESyne BD(TM) Novolimus Eluting Coronary Stent with Biodegradable Polymer
Devices Interventional Cardiology
 HSMN NewsFeed - 15 May 2012
Arterial Remodeling Technologies (“ART”) receives regulatory approval to begin First-In-Man “ARTDIVA” clinical trial with its next-generation bioresorbable stent
Devices Interventional Cardiology
 HSMN NewsFeed - 7 Mar 2012
Abbott's Absolute Pro(R) Vascular Self-Expanding Stent System Receives FDA Approval for Treatment of Iliac Artery Disease
Devices Interventional FDA
 HSMN NewsFeed - 5 Jan 2012
Biomerix Receives CE Mark Approval For ASSURE Soft Tissue Repair Mesh
Devices Surgery Regenerative Medicine Regulatory
 HSMN NewsFeed - 22 Dec 2011
Abbott Initiates Clinical Trial to Study Drug Eluting Bioresorbable Therapy for Treatment of Peripheral Artery Disease
Devices Interventional
 HSMN NewsFeed - 8 Dec 2011
Abbott Initiates Clinical Trial to Evaluate the Absorb(TM) Bioresorbable Vascular Scaffold Compared to a Metallic Drug Eluting Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 15 Nov 2011
Innocoll Enters Partnership with Merus Labs in Canada for the Distribution of CollaGUARD
Devices Distribution
 HSMN NewsFeed - 11 Oct 2011
Innocoll Announces European Approval for CollaGUARD(R), Surgical Adhesion Barrier
Devices Surgery Regulatory
 HSMN NewsFeed - 8 Sep 2011
Abbott Initiates International ABSORB BTK Clinical Trial for Treatment of Below-the-Knee Critical Limb Ischemia
Devices
 HSMN NewsFeed - 25 Feb 2011
REVA Expands Management Team With Key Executive Hire
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 10 Jan 2011
Abbott Receives CE Mark Approval for World's First Drug Eluting Bioresorbable Vascular Scaffold for Treatment of Coronary Artery Disease
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 7 Dec 2010
Arterial Remodeling Technologies (“ART”) Discloses New Data for Its Breakthrough Bioresorbable Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 9 Nov 2010
Kensey Nash and Arthrex Announce European Distribution Agreement for the Cartilage Repair Device
Regenerative Medicine Orthopaedic Distribution
 HSMN NewsFeed - 22 Sep 2010
Abbott's Fully Bioresorbable Vascular Scaffold Technology Continues to Demonstrate Strong Clinical Results
Devices Interventional Cardiology
 HSMN NewsFeed - 17 Sep 2010
Elixir Medical Corporation Initiates Enrollment in the EXCELLA BD Randomized Clinical Trial of the Elixir Novolimus Eluting Coronary Stent System with Bioabsorbable Polymer
Devices Interventional Cardiology
 HSMN NewsFeed - 25 May 2010
Abbott's Groundbreaking Bioresorbable Technology Continues to Demonstrate Exceptional Clinical Results
Devices Interventional Cardiology
 HSMN NewsFeed - 4 Jan 2010
Arterial Remodeling Technologies ("ART") To Report That Its Bioresorbable Stent Platform Restores the Remodeling Capacity of Arterial Walls
Devices Interventional Cardiology
 HSMN NewsFeed - 5 Nov 2009
Alphatec Spine, Inc. Enters Supply and Distribution Agreement With ETEX Corporation for Novel Biologics Products
Devices Distribution Neurosurgery Orthopaedic
 HSMN NewsFeed - 7 Aug 2009
Kensey Nash Announces Agreement to Acquire Rights to OsseoFit Product
Devices Distribution
 HSMN NewsFeed - 28 May 2009
SyntheMed Receives Australian Regulatory Approval for REPEL-CV(R)
Devices Regulatory
 HSMN NewsFeed - 9 Mar 2009
FDA Approves SyntheMed's REPEL-CV(R) Adhesion Barrier for Use in Pediatric Cardiac Surgery
Devices Surgery Cardiology FDA
 HSMN NewsFeed - 14 Jan 2009
Orthomimetics Secures CE Mark Approval for Chondromimetic
Devices Regenerative Medicine Orthopaedic Regulatory
 HSMN NewsFeed - 26 Sep 2008
TyRx Launches AIGISRX(TM) ICD to Reduce Surgical Site Infections Associated With Implantable Cardioverter Defibrillators
Devices Cardiology
 HSMN NewsFeed - 18 Jul 2008
SyntheMed Appoints Corinne Mundin as Director, International Market Development
Devices Personnel
 HSMN NewsFeed - 24 Mar 2008
Bioresorbable Stent Company, Arterial Remodeling Technologies (''ART''), Appoints Machiel Van Der Leest as Chief Operating Officer
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 17 Jan 2008
TyRx Pharma, Inc. Announces Food and Drug Administration (FDA) 510(k) Clearance of the AIGIS(Rx)(TM) Cardiac Rhythm Medical Device (CRMD) Anti-Bacterial Envelope, an Innovative Mesh Envelope Designed to Immobilize and Reduce Bacterial Infection of a Pacem
Devices Biopharmaceuticals FDA Cardiology
 HSMN NewsFeed - 8 Jan 2008
TyRx Pharma, Inc. Announces the Appointment of Robert M. (Bob) Mattioli as Vice President, Commercial Development
Devices Personnel
 HSMN NewsFeed - 4 Jan 2008
Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain
Devices Surgery Pain Management
 HSMN NewsFeed - 17 Dec 2007
Bard to License Hernia Product and Technology from Genzyme Corporation
Devices Licensing
 HSMN NewsFeed - 17 Oct 2007
Innocoll Files Investigational New Drug Application for its CollaRx(R) BUPIVACAINE TOPICAL for the Treatment of Painful Chronic Skin Ulcers and Burns
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 20 Sep 2007
FDA Panel Recommends Approval of SyntheMed's REPEL-CV(R) Adhesion Barrier for Pediatric Patients
Devices Surgery FDA
 HSMN NewsFeed - 12 Sep 2007
Innocoll Enters Into Collaboration With TGR Biosciences for Development of a Novel Wound Healing Product
Biopharmaceuticals Drug Delivery Wound Care
 HSMN NewsFeed - 13 Aug 2007
TyRx Pharma, Inc., Announces the Hiring of Mark Citron as Vice President, Clinical and Regulatory Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Jul 2007
Bioresorbable Collagen Scaffold Placed inside the Heart Revolutionizes Treatment
Devices Interventional Cardiology Regenerative Medicine
 HSMN NewsFeed - 1 Jun 2007
Kensey Nash Announces Acquisition of Assets of MacroPore Biosurgery Business Unit from Cytori Therapeutics
Devices Orthopaedic Neurosurgery Acquisitions
 HSMN NewsFeed - 31 May 2007
Brian Ennis Appointed President and Chief Executive Officer of ETEX Corporation
Devices Personnel
 HSMN NewsFeed - 2 May 2007
SyntheMed Appoints Marc Sportsman as Vice President of Sales
Devices Surgery Drug Delivery Personnel
 HSMN NewsFeed - 4 Apr 2007
Innocoll Receives FDA Approval to Commence Phase 2 Clinical Development with its CollaRx(R) BUPIVACAINE IMPLANT for the Management of Post-operative Pain
Devices Surgery
 HSMN NewsFeed - 29 Mar 2007
Innocoll Files US and Irish Patent Applications for its CollaRx(R) BUPIVACAINE IMPLANT for the Management of Post-operative Pain
Devices Surgery
 HSMN NewsFeed - 28 Mar 2007
FDA Accepts Synthemed's Pre-Market Approval (PMA) Application for REPEL-CV(R)
Devices Surgery FDA
 HSMN NewsFeed - 15 Mar 2007
Tornier and Bioretec Announce Partnership in Bioresorbable Orthopedic Products
Devices Orthopaedic
 HSMN NewsFeed - 17 Jan 2007
CryoLife Signs Agreement With MAST Biosurgery, Inc. to Distribute CardioWrap(TM) in U. S.
Devices Cardiology Surgery Distribution
 HSMN NewsFeed - 16 Oct 2006
TyRx Pharma, Inc. Announces Submission of a Premarket Application for PIVIT(TM) CRM, an Innovative Mesh Pouch Designed to Hold and Reduce Bacterial Colonization of a Pacemaker or Implantable Defibrillator Pulse Generator (ICD) When Implanted in the Body
Devices Cardiology FDA
 HSMN NewsFeed - 5 Oct 2006
Conor Medsystems Receives Approval for One-Year Shelf Life for CoStar(R) Stent in the European Union
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 27 Sep 2006
Kensey Nash Announces 510(K) Clearance for Proprietary Bone Void Filler
Devices Orthopaedic FDA
 HSMN NewsFeed - 6 Sep 2006
SyntheMed Announces Positive Pivotal Clinical Trial Results for REPEL-CV(R)
Devices Surgery
 HSMN NewsFeed - 24 Jul 2006
TyRx Pharma, Inc., Announces FDA Clearance of PIVIT(TM) AB, a Novel Antimicrobial-Coated Surgical Mesh
Devices Surgery FDA
 HSMN NewsFeed - 18 May 2006
Conor Medsystems Announces First Patient Treated with Dual-Drug Coronary Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 11 May 2006
Conor Medsystems Initiates RAPID Clinical Study for First Pimecrolimus Drug-Eluting Stent
Devices Interventional Cardiology
Return to NewsFeed  

 Additional items found! 61

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 61 additional stories matching:
bioresorbable
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!